1. Home
  2. ALT vs PRE Comparison

ALT vs PRE Comparison

Compare ALT & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$2.76

Market Cap

421.5M

Sector

Health Care

ML Signal

HOLD

Logo Prenetics Global Limited

PRE

Prenetics Global Limited

HOLD

Current Price

$20.13

Market Cap

337.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALT
PRE
Founded
1997
2014
Country
United States
Hong Kong
Employees
N/A
98
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
421.5M
337.6M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
ALT
PRE
Price
$2.76
$20.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$17.67
$30.50
AVG Volume (30 Days)
2.8M
265.1K
Earning Date
05-08-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
25.37
N/A
EPS
N/A
N/A
Revenue
$41,000.00
N/A
Revenue This Year
N/A
$108.69
Revenue Next Year
N/A
$58.68
P/E Ratio
N/A
N/A
Revenue Growth
105.00
N/A
52 Week Low
$2.56
$7.18
52 Week High
$7.73
$23.63

Technical Indicators

Market Signals
Indicator
ALT
PRE
Relative Strength Index (RSI) 42.50 55.34
Support Level $2.57 $17.44
Resistance Level $4.19 $21.03
Average True Range (ATR) 0.12 1.53
MACD -0.00 -0.02
Stochastic Oscillator 27.34 58.05

Price Performance

Historical Comparison
ALT
PRE

About ALT Altimmune Inc.

Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.

Share on Social Networks: